Capital Adept
  • Politics
  • Investing
  • Stocks
  • Business
  • Politics
  • Investing
  • Stocks
  • Business

Capital Adept

Politics

Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

by admin April 16, 2025
April 16, 2025
Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

A top advisor to Defense Secretary Pete Hegseth was escorted out of the Pentagon on Tuesday and placed on administrative leave, according to a Defense Department official. 

Reuters first reported Caldwell had been placed on leave for an ‘unauthorized disclosure’ of information amid an investigation into Pentagon leaks. An official confirmed to Fox News Digital that Reuters’ reporting is accurate but declined to comment on an ongoing investigation. 

Caldwell previously worked at restraint-minded think tank Defense Priorities and Concerned Veterans for America, a group formerly led by Hegseth. A foreign policy realist, he has argued that the U.S. should dramatically reduce its footprint in Europe and pull out forces in Iraq and Syria. 

Last month, the Defense Department announced a probe into ‘recent unauthorized disclosures of national security information’ and said it planned to use polygraphs to determine the source of leaks. 

‘The use of polygraphs in the execution of this investigation will be in accordance with applicable law and policy,’ DOD Chief of Staff Joe Kasper wrote in a memo. ‘This investigation will commence immediately and culminate in a report to the Secretary of Defense.’

He wrote that ‘information identifying a party responsible for an unauthorized disclosure’ would be referred for criminal prosecution.

Caldwell did not immediately reply to a request for comment. 

Caldwell’s closeness to the defense secretary was underscored in the unintentionally leaked Signal chat on Houthi strikes, where Hegseth named him as the Pentagon point of contact for the offensive campaign. 

This post appeared first on FOX NEWS

previous post
Soaring Medicare prescription drug prices targeted in Trump’s new executive order
next post
Trump directs agencies to follow Supreme Court rulings, as he continues to rein in administrative state

Related Posts

Hakeem Jeffries demands Trump ‘justify’ striking Iran, but...

June 24, 2025

Arrest of Chinese nationals in swing state, Israel’s...

June 21, 2025

Third top Pentagon aide Collin Carroll on administrative...

April 17, 2025

Germany poised to get new conservative chancellor Friedrich...

April 30, 2025

Joe Biden diagnosed with ‘aggressive form’ of prostate...

May 19, 2025

Dr. Oz young family member faints during Trump’s...

April 19, 2025

Trump admin secures release of American missionary held...

April 14, 2025

US Ambassador to Israel Mike Huckabee indicates US...

June 20, 2025

Trump targets massive investments in first Middle East...

May 13, 2025

Pandemic, price tags and privacy concerns: Why it...

April 22, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      The Best Five Sectors, #10

      March 14, 2025
    • 2

      5 Strong Stocks Defying the Bearish Market!

      March 14, 2025
    • 3

      DP Trading Room: Market Sell-Off

      March 14, 2025
    • 4

      Sector Rotation Warning: More Downside Ahead for US Markets?

      March 14, 2025
    • 5

      Transform Your Investing Strategy: Uncover the 3 Game-Changing Rules

      March 14, 2025
    • 6

      CHARBONE Hydrogene et ABB signent une entente pour accelerer les usines de production d’hydrogene vert en Amerique du Nord

      March 14, 2025
    • 7

      Did Friday’s Reversal Mark A Major Bottom?

      March 14, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 capitaladept.com | All Rights Reserved